Chopra Rajat, Bhatt Rama, Biswas S K, Bhalla R
Consultant Orthopaedics, Sir Ganga Ram Hospital, New Delhi 110060, India.
District Tuberculosis Officer, Ramakrishna Mission Free TB Clinic, New Delhi 110005, India.
Indian J Tuberc. 2018 Jan;65(1):70-75. doi: 10.1016/j.ijtb.2017.08.029. Epub 2017 Oct 5.
To assess the efficacy of alternate day (thrice a week) Directly Observed Treatment Short-course (DOTS) regimen spanning six to nine months in providing sustained cure for skeletal tuberculosis (TB) under programmatic conditions.
Retrospective cohort study.
An urban district tuberculosis centre in India under the Revised National Tuberculosis Programme.
A cohort of 218 patients treated with alternate day DOTS regimen for skeletal TB between 2007 and 2012.
All patients with the diagnosis of skeletal TB registered between 2007 and 2012 who successfully completed treatment were followed up for evidence of disease recurrence or relapse using structured interviews conducted between August 2013 and October 2015 after ensuring a minimum follow up of two years.
Of the 200 patients eligible for follow up in this study, 117 (58.5%) had a minimum follow up of two years. The remaining 83 cases could not be traced. 105 (89.7%) of these 117 patients were symptom free for two years or more after the completion of treatment. There were four cases who had a relapse of the disease within two years of completion of treatment. Eight cases were administered further ATT soon after the completion of treatment under DOTS.
This study confirms the efficacy of the alternate day DOTS regimen in successfully treating all forms of skeletal TB, including spinal TB, with a success rate of 89.7%.
评估在项目条件下,为期六至九个月的隔日(每周三次)直接观察治疗短程疗法(DOTS)方案对骨结核提供持续治愈的疗效。
回顾性队列研究。
印度一个市区结核病中心,隶属于修订后的国家结核病规划。
2007年至2012年间接受隔日DOTS方案治疗骨结核的218名患者队列。
对2007年至2012年间确诊为骨结核且成功完成治疗的所有患者进行随访,在确保至少随访两年后,于2013年8月至2015年10月期间通过结构化访谈收集疾病复发或再发的证据。
本研究中符合随访条件的200名患者中,117名(58.5%)至少随访了两年。其余83例无法追踪。这117名患者中有105名(89.7%)在完成治疗后两年或更长时间内无症状。有4例在完成治疗后两年内疾病复发。8例在DOTS方案完成治疗后不久接受了进一步的抗结核治疗。
本研究证实了隔日DOTS方案成功治疗包括脊柱结核在内的所有形式骨结核的疗效,成功率为89.7%。